Stock Analysis on Net
Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Beginner level

AbbVie Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Short-term borrowings 0.02 0.04 0.04 0.01 0.00 0.00 0.54 0.88 6.23 4.54 5.70 0.53 0.57 1.16 0.60 0.61 0.57 0.00 0.73 0.74
Current portion of long-term debt and finance lease obligations 5.62 3.16 3.55 4.12 4.21 8.88 9.34 2.78 2.71 1.54 4.90 8.67 8.50 4.39 4.51 0.04 0.04 0.04 0.03 3.77
Accounts payable and accrued liabilities 13.39 12.97 12.89 13.94 13.28 20.55 19.78 20.83 20.10 17.18 17.35 15.40 14.45 13.38 13.19 12.82 14.19 13.62 13.03 15.34
Current liabilities 19.04% 16.16% 16.48% 18.06% 17.49% 29.43% 29.65% 24.49% 29.05% 23.26% 27.94% 24.60% 23.51% 18.93% 18.30% 13.47% 14.80% 13.66% 13.80% 19.85%
Long-term debt and finance lease obligations, excluding current portion 51.51 54.99 54.88 69.39 70.67 55.73 55.33 61.77 58.97 55.15 49.61 44.57 43.73 49.35 50.48 55.63 55.13 55.96 55.54 54.90
Deferred income taxes 2.42 3.00 3.20 1.05 1.27 1.78 2.01 1.97 1.80 2.25 2.71 3.32 3.52 8.93 9.54 10.35 10.42 9.19 10.68 10.07
Other long-term liabilities 18.34 15.63 15.59 19.63 19.75 26.90 28.00 25.56 24.41 23.76 25.22 22.38 22.05 13.07 12.71 12.94 12.64 11.48 11.59 6.54
Long-term liabilities 72.27% 73.62% 73.67% 90.07% 91.68% 84.41% 85.34% 89.29% 85.18% 81.16% 77.53% 70.28% 69.29% 71.35% 72.73% 78.92% 78.19% 76.63% 77.81% 71.51%
Total liabilities 91.30% 89.78% 90.15% 108.13% 109.17% 113.84% 114.99% 113.79% 114.23% 104.41% 105.48% 94.88% 92.80% 90.29% 91.03% 92.39% 92.99% 90.29% 91.61% 91.36%
Common stock, $0.01 par value 0.01 0.01 0.01 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Common stock held in treasury, at cost -1.50 -1.32 -1.31 -27.53 -27.50 -41.22 -42.88 -43.16 -40.62 -33.02 -33.82 -19.23 -16.84 -16.59 -17.06 -17.41 -16.42 -13.15 -12.47 -16.60
Additional paid-in-capital 11.55 11.46 11.34 16.89 17.05 25.42 26.30 26.32 24.86 22.19 23.68 20.94 20.16 20.56 20.92 21.15 20.69 20.32 19.41 24.74
Retained earnings 0.70 2.23 2.09 6.55 5.29 6.18 5.92 7.46 5.67 10.26 8.91 7.18 7.71 9.51 8.88 7.71 6.62 6.02 4.98 4.98
Accumulated other comprehensive loss -2.07 -2.18 -2.30 -4.05 -4.04 -4.25 -4.36 -4.43 -4.18 -3.87 -4.28 -3.79 -3.85 -3.80 -3.80 -3.87 -3.91 -3.51 -3.56 -4.51
Stockholders’ equity (deficit) 8.68% 10.21% 9.84% -8.13% -9.17% -13.84% -14.99% -13.79% -14.23% -4.41% -5.48% 5.12% 7.20% 9.71% 8.97% 7.61% 7.01% 9.71% 8.39% 8.64%
Noncontrolling interest 0.01 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total equity (deficit) 8.70% 10.22% 9.85% -8.13% -9.17% -13.84% -14.99% -13.79% -14.23% -4.41% -5.48% 5.12% 7.20% 9.71% 8.97% 7.61% 7.01% 9.71% 8.39% 8.64%
Total liabilities and equity (deficit) 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (filing date: 2021-02-19), 10-Q (filing date: 2020-11-04), 10-Q (filing date: 2020-08-04), 10-Q (filing date: 2020-05-08), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-11-06), 10-Q (filing date: 2019-08-05), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-07), 10-Q (filing date: 2018-08-07), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-11-07), 10-Q (filing date: 2017-08-07), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-11-07), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. AbbVie Inc.’s current liabilities as a percentage of total liabilities and equity (deficit) decreased from Q2 2020 to Q3 2020 but then increased from Q3 2020 to Q4 2020 exceeding Q2 2020 level.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. AbbVie Inc.’s long-term liabilities as a percentage of total liabilities and equity (deficit) decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. AbbVie Inc.’s total liabilities as a percentage of total liabilities and equity (deficit) decreased from Q2 2020 to Q3 2020 but then increased from Q3 2020 to Q4 2020 exceeding Q2 2020 level.
Stockholders’ equity (deficit) Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. AbbVie Inc.’s stockholders’ equity (deficit) as a percentage of total liabilities and equity (deficit) increased from Q2 2020 to Q3 2020 but then decreased significantly from Q3 2020 to Q4 2020.